Syndromic Testing Products
Syndromic Testing

QIAstat-Dx products

QIAstat-Dx Analyzer

The next generation of syndromic insights

The size of a small printer, the QIAstat-Dx Analyzer can provide your lab with simultaneous qualitative detection and identification of multiple pathogens. With just one panel test, comprehensive results are around an hour away. The QIAstat-Dx Analyzer runs with all-in-one cartridges that contain preloaded reagents. Setting up a test takes less than one minute hands-on time and there's no need for precision pipetting. Powered by QIAstat-Dx, your lab can accelerate diagnosis and help improve patient care with rapid and accurate treatment.
Experience the easy workflow

See how quick and intuitive multiplex syndromic testing can be. Use this interactive demo to try out the QIAstat-Dx Analyzer for yourself.

Try the demo
QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge, sample prep, scan
Could your lab benefit from having a QIAstat-Dx?
Make the right choice for your lab.
Get a quote
QIAstat-Dx Analzyer and QIAstat-Dx Rise features

With the QIAstat-Dx family of analyzers, we have an instrument for every lab. Regardless of the configuration, all analyzers have modular options allowing for customization for your lab. And they all run assays using our preloaded cartridges and intuitive touchscreen display.

QIAstat-Dx Analyzer
Hands-on time Less than one minute
Test turnaround time 67–75 minutes (dependant on assay)
Throughput per day (24 hr) Up to 84 samples
Ct values and amplification curves Viewable for all detected pathogens
Interface Intuitive touchscreen
Connectivity Seamless integration with QIAsphere
LIS/LIMS Bidirectional capabilities
Batch testing with configurable queue Batch process 18 tests in a single run
Epidemiology reports Data and dashboard service through QIAsphere*
Continuous loading + urgent testing Each analytical module runs independently
Remote instrument status Available through QIAsphere*
Remote monitoring service Available through QIAsphere*

Get connected with QIAsphere

QIAstat-Dx, QIAsphere, woman, lab, doctor
All the QIAstat-Dx capabilities at your fingertips

Using the QIAsphere app alongside your local network or cloud connection, you can remotely monitor your QIAstat-Dx Analyzer.

You’re free to walk away from your instruments while keeping track of test monitoring. And you can maximize use of your QIAstat-Dx Analyzer by reducing instrument downtime. 

Learn more about QIAsphere

Discover the assay menu

All QIAstat-Dx panels harness the power of our sleek cartridge design. This technology redefines ease-of use for multiplex testing by creating a workflow with less than one minute hands-on time.

  • Save time – all reagents are preloaded into the cartridge
  • Reduce errors and risk of contamination – tests are performed on a single instrument solution
  • Lower costs – cartridges are shipped and stored at room temperature
QIAstat Respiratory SARS-CoV-2 Panel
QIAstat Respiratory SARS-CoV-2 Panel

This expanded version of our multiplex respiratory cartridge detects and differentiates† 21 viral and bacterial respiratory targets, including SARS-CoV-2 to support efforts to provide accessible testing to meet the demands of the COVID-19 outbreak.

Download flyer

†Enterovirus and Rhinovirus are both detected, but not differentiated, with the QIAstat-Dx Respiratory SARS-CoV-2 Panel.

Learn more
Coming soon: QIAstat-Dx Gastrointestinal Panel
Coming soon: QIAstat-Dx Gastrointestinal Panel

One of the next panels to join the QIAstat-Dx assay menu will be available soon.

Notify me
Coming soon: QIAstat-Dx Meningitis/Encephalitis Panel
Coming soon: QIAstat-Dx Meningitis/Encephalitis Panel
One of the next panels to join the QIAstat-Dx assay menu will be available soon.
Notify me

* Some features require a QIAstat-Dx Connectivity plan. Flexible plans are available to meet your lab’s needs.

The QIAstat-Dx Analyzer is intended for in vitro diagnostic use.

The QIAstat-Dx Respiratory SARS-CoV-2 Panel is intended for in vitro diagnostic use. 

  • This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; 
  • This product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and 
  • This emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetics Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declarations is terminated or authorization is revoked sooner.